Free Shipping on all Orders - No Minimums!

  • Home
  • Shop
  • Your Microbiome
  • Advanced Daily
  • About
  • Clinical Trial Services
  • Research Studies
  • Testimonials
  • More
    • Home
    • Shop
    • Your Microbiome
    • Advanced Daily
    • About
    • Clinical Trial Services
    • Research Studies
    • Testimonials
  • Sign In
  • Create Account

  • Orders
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Orders
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Shop
  • Your Microbiome
  • Advanced Daily
  • About
  • Clinical Trial Services
  • Research Studies
  • Testimonials

Account


  • Orders
  • My Account
  • Sign out


  • Sign In
  • Orders
  • My Account

Research Studies

BiotiQuestTM Sugar Shift

Trial

Effect of the dietary supplement BiotiQuestTM Sugar Shift in the management of type 2 diabetes mellitus (T2DM).

Outcome

G. García et al., Metabolic Shifting Probiotic in Type2 Diabetes Mellitus Management: Randomized Clinical Trial. Journal of Biotechnology and Biomedicine. 6 (2023): 270-280

Kesto Mix

Trial

Effect of the dietary supplement Kesto Mix in the management of type 2 diabetes mellitus (T2DM).

Outcome

G. García et al., Short- Chain Fructooligosaccharides Improve Gut Microbiota Composition in Patients with Type 2 Diabetes. A randomized, Open-Label, Controlled Pilot Clinical Trial. Journal of Biotechnology and Biomedicine. 6 (2023): 244-258.

Metagenomic Biomarkers

Trial

Metagenomic biomarkers in colorectal cancer tissues.

Outcome

G. García et al., From Colon Wall to Tumor Niche: Unraveling the Microbiome's Role in Colorectal Cancer Progression. SUBMITTED: PLOS ONE 3/2024

Bacillus Coagulans AO1167

Trial

Safety evaluation of Bacillus coagulans AO1167 for its use as a probiotic in humans.

Outcome

Randomized clinical trials demonstrate the safety assessment of Bacillus coagulans AO1167 for use as a probiotic in humans. IN PREPARATION

Bacillus Clausii AO1125

Trial

Safety evaluation of Bacillus clausii AO1125 for its use as a probiotic in humans.

Outcome

Randomized clinical trials demonstrate the safety assessment of Bacillus clausii AO1125 for use as a probiotic in humans. IN PREPARATION

Chauvell | San Luis Obispo, California, USA

Copyright © 2024 Chauvell LLC - All Rights Reserved.